Pfizer CentreOne expands fill-finish services to its Michigan facility

The site in Kalamazoo provides vial-filling of small and large molecules plus sterile suspensions

Global contract manufacturing organisation Pfizer CentreOne has expanded its fill-finish services to its site in Kalamazoo, Michigan (USA).

Along with vial-filling of small molecules and biologics, the facility also provides vial-filling of sterile suspensions, expanding Pfizer CentreOne’s service portfolio.

“Kalamazoo was the obvious choice for expansion of our fill-finish services,” said Peter Stevenson, Pfizer CentreOne’s Vice President and General Manager.

“Our Kalamazoo colleagues have been doing contract manufacturing for more than 40 years on the API side – it’s part of the culture.”

“This is also one of Pfizer’s premier sterile-injectables sites. It’s a natural fit,” he said.

Kalamazoo vial-filling services Services at the Kalamazoo site encompass:

  • Small molecules and biologics
  • Sterile suspensions
  • Potent and controlled substances
  • Aqueous and oil-based formulations
  • Lyophilisation
  • Vials 1-100mL; bulk formulation <1–1,600 litres

Bob Betzig, Kalamazoo site head, said: “We’re thrilled to expand our contract manufacturing services to include sterile injectables. We value our contract manufacturing partners and pride ourselves on producing difficult-to-make injectables. Our team is ready and waiting.”

Companies